Jane Street’s SQZ Biotechnologies Company SQZ Stock Holding History

Jane Street’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-42,919	Closed	-$31.8K	–	10345
2022 Q4	$31.8K	Buy	+42,919	New	+$93.7K	﹤0.01%	8488

Other funds holding SQZ

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's SQZ Position: Q1 2023 in Review

Jane Street sold out of SQZ Biotechnologies Company (SQZ) in Q1 2023, closing a stake of 42,919 shares — an estimated $31.8K sold.

Jane Street first reported a position in SQZ in Q4 2022 and held it in 1 quarter. The position peaked at $31.8K in Q4 2022. 32 funds tracked by Wall St. Rank hold SQZ as of Q1 2023.

Jane Street reported no remaining SQZ Biotechnologies Company position as of Q1 2023 after selling out during the quarter.
Jane Street sold 42,919 SQZ Biotechnologies Company shares in Q1 2023, an estimated $31.8K.
Jane Street first reported a position in SQZ Biotechnologies Company in Q4 2022 and held it in 1 quarter.
Jane Street's SQZ Biotechnologies Company position peaked at $31.8K in Q4 2022.
32 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.